Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Groen

Showing results (331-340 of 564) with videos related to

Pageof 57
Sort By:
Scientific Reports|July 18, 2015
The detection of EpCAM(+) and EpCAM(-) circulating tumor cellsSanne de Wit, Guus van Dalum, Aufried T M Lenferink, et al.
Acta Neurologica Scandinavica|August 27, 2021
Presenting symptoms and functional outcome of chronic subdural hematoma patientsJurre Blaauw, Ghislaine A Meelis, Bram Jacobs, et al.
The Journal of Pathology|April 1, 2009
Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancerMirjam C Boelens, Anke van den Berg, Rudolf S N Fehrmann, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Quantification of growth patterns of screen-detected lung cancers: The NELSON studyMarjolein A Heuvelmans, Rozemarijn Vliegenthart, Harry J de Koning, et al.
Cancers|July 27, 2022
The Presence of EGFR T790M in TKI-Naïve Lung Cancer Samples of Patients Who Developed a T790M-Positive Relapse on First or Second Generation TKI Is RareWeiting Li, Klaas Kok, Geok Wee Tan, et al.
Translational Lung Cancer Research|November 19, 2019
Comparison of Veterans Affairs, Mayo, Brock classification models and radiologist diagnosis for classifying the malignancy of pulmonary nodules in Chinese clinical populationXiaonan Cui, Marjolein A Heuvelmans, Daiwei Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancerEgbert F Smit, Sjaak A Burgers, Bonne Biesma, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2023
Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the GEOMETRY mono-1 studyJürgen Wolf, Edward B Garon, Harry J M Groen, et al.
European Journal of Neurology|March 16, 2024
Re-evaluating patient communication and care in angiographically negative subarachnoid hemorrhage: Balancing realism and optimismSara Khosdelazad, Jacoba M Spikman, Sofie Solvang, et al.
Journal of the National Cancer Center|July 22, 2024
Cost-effectiveness of lung cancer screening by low-dose CT in China: a micro-simulation studyYihui Du, Yanju Li, Grigory Sidorenkov, et al.
Pageof 57

Showing results (331-340 of 564) with videos related to

Sort By:
Pageof 57
Scientific Reports|July 18, 2015
The detection of EpCAM(+) and EpCAM(-) circulating tumor cellsSanne de Wit, Guus van Dalum, Aufried T M Lenferink, et al.
Acta Neurologica Scandinavica|August 27, 2021
Presenting symptoms and functional outcome of chronic subdural hematoma patientsJurre Blaauw, Ghislaine A Meelis, Bram Jacobs, et al.
The Journal of Pathology|April 1, 2009
Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancerMirjam C Boelens, Anke van den Berg, Rudolf S N Fehrmann, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
Quantification of growth patterns of screen-detected lung cancers: The NELSON studyMarjolein A Heuvelmans, Rozemarijn Vliegenthart, Harry J de Koning, et al.
Cancers|July 27, 2022
The Presence of EGFR T790M in TKI-Naïve Lung Cancer Samples of Patients Who Developed a T790M-Positive Relapse on First or Second Generation TKI Is RareWeiting Li, Klaas Kok, Geok Wee Tan, et al.
Translational Lung Cancer Research|November 19, 2019
Comparison of Veterans Affairs, Mayo, Brock classification models and radiologist diagnosis for classifying the malignancy of pulmonary nodules in Chinese clinical populationXiaonan Cui, Marjolein A Heuvelmans, Daiwei Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancerEgbert F Smit, Sjaak A Burgers, Bonne Biesma, et al.
European Journal of Cancer (Oxford, England : 1990)|February 23, 2023
Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the GEOMETRY mono-1 studyJürgen Wolf, Edward B Garon, Harry J M Groen, et al.
European Journal of Neurology|March 16, 2024
Re-evaluating patient communication and care in angiographically negative subarachnoid hemorrhage: Balancing realism and optimismSara Khosdelazad, Jacoba M Spikman, Sofie Solvang, et al.
Journal of the National Cancer Center|July 22, 2024
Cost-effectiveness of lung cancer screening by low-dose CT in China: a micro-simulation studyYihui Du, Yanju Li, Grigory Sidorenkov, et al.
Pageof 57